Please disable your Ad Blocker to better interact with this website.


The CEO Who Price Gouged “EpiPen” is a Democrat Senator’s Daughter

The drug company Mylan is under fire for price-gouging the life-saving allergy drug, EpiPen. While Democrats are collectively freaking out, it is worth noting that the company’s CEO is none other than the daughter of Democratic Senator Joe Manchin (WV).

Thanksgiving will be a little awkward in the Manchin house this year.

The Washington Free Beacon reports:

Sen. Joe Manchin (D., W.Va.) is in an “awkward position” after his daughter, Mylan CEO Heather Bresch, spiked the price of the life-saving allergy EpiPen from $100 in 2009 to between $600 and $700 today, NBC’s Kristen Welker said Friday.

“With calls mounting for a congressional investigation, the controversy is putting her father West Virginia Senator Joe Manchin, in an awkward position,” Welker said.

On Thursday, Manchin released a statement saying that he plans to work with his colleagues to lower the price of prescription drugs.

… Bresch defended her $19 million salary on CNBC Thursday by saying that “facts are inconvenient to headlines.” Bresch went on to blame the “broken” healthcare system and said that every person who needs an EpiPen has access to one because of her company’s lobbying to force schools, airports and hotels to stock the allergy injection.

After celebrity actress Sarah Jessica Parker waved goodbye to her personal association with the company, Mylan decided to “compromise” by giving out $300 rebate cards to customers.

How generous.

Tom Borelli

Dr. Tom Borelli is a Newsmax TV contributor and radio commentator addressing political issues from a conservative grassroots perspective. As a columnist, he has written for The Washington Times and authored articles for Newsmax Magazine, Newsmax Insider and previously was a co-host with his wife Deneen Borelli on the SiriusXM Patriot channel. Dr. Borelli appeared on numerous television programs, including the highly ranked Fox News Channel’s “The O’Reilly Factor,” “Hannity,” “The Kelly File," and "America’s News Headquarters." He has also appeared on Fox Business Network’s “Making Money with Charles Payne” and “After the Bell” as well as TheBlaze TV’s "The Glenn Beck Program" and "Dana!" Prior to working for public policy organizations, Dr. Borelli was a managing partner with the investment advisory firm of Action Fund Management, LLC and a portfolio manager for the Free Enterprise Action Fund (FEAF) where he used shareholder activism to challenge corporations that sought to profit from the growth of government. During his 25 years with the Altria Group, Inc., he built a foundation in public policy and issues management, drawing from diverse experiences ranging from basic research to corporate affairs. Dr. Borelli served as science fellow for the U.S. House of Representatives' Committee on Science, Space, and Technology during the 100th Congress. Dr. Borelli has also published scientific papers on interferon and human leukemia.

Related Articles